Results from viability assays demonstrated that Akt silencing significantly reduced cell viability (Appendix Fig S9C), indicating that Akt is important for the growth of EGFR mutant and wild‐type TKI‐resistant NSCLC cells. The gene discussed is AKT1; the disease is non-small cell lung carcinoma.